메뉴 건너뛰기




Volumn 2, Issue 2, 2006, Pages 76-77

Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis?

Author keywords

Atorvastatin; Hemodialysis; Statins; Stroke; Type 2 diabetes

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

EID: 33644825613     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0101     Document Type: Note
Times cited : (8)

References (5)
  • 1
    • 3242667376 scopus 로고    scopus 로고
    • Kidney disease as a risk factor for recurrent cardiovascular disease and mortality
    • Weiner DE et al. (2004) Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 44: 198-206
    • (2004) Am J Kidney Dis , vol.44 , pp. 198-206
    • De Weiner1
  • 2
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 3
    • 4344683381 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial
    • Colhoun HM et al. (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364: 685-696
    • (2004) Lancet , vol.364 , pp. 685-696
    • Colhoun, H.M.1
  • 4
    • 0036147221 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients
    • Seliger SL et al. (2002) HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int 61: 297-304
    • (2002) Kidney Int , vol.61 , pp. 297-304
    • Seliger, S.L.1
  • 5
    • 84858569153 scopus 로고    scopus 로고
    • online 1 September
    • United States Renal Data System (online 1 September 2005) [http://www.usrds.org] (accessed 1 September 2005)
    • (2005)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.